{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:26:10Z","timestamp":1793625970614,"version":"4.5.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016658","name":"National Plan on Drugs","doi-asserted-by":"publisher","award":["2022-PN060"],"award-info":[{"award-number":["2022-PN060"]}],"id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Government of Galicia Department of Education Science Universities and Professional Training","doi-asserted-by":"publisher","award":["ED431C 2025\/21"],"award-info":[{"award-number":["ED431C 2025\/21"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.forsciint.2026.113102","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:35:05Z","timestamp":1786084505000},"page":"113102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LC-HRMS suspect screening for expanded detection of (new) psychoactive substances in oral fluid: a practical approach for forensic casework"],"prefix":"10.1016","volume":"388","author":[{"given":"Miriam","family":"Blanco-Ces","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lendoiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Cobo-Golpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"L\u00f3pez-Rabu\u00f1al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelines","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-012X","authenticated-orcid":false,"given":"Ana","family":"de-Castro-R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2026.113102_bib1","unstructured":"European Union Drugs Agency (EUDA). New Psychoactive Substances (NPS) [Internet]. EUDA: Luxembourg; accessed Jan 7, 2026."},{"key":"10.1016\/j.forsciint.2026.113102_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpba.2016.06.046","article-title":"Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis","volume":"130","author":"Mercolini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/dta.2577","article-title":"Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM)","volume":"11","author":"Grumann","year":"2019","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bcpt.13786","article-title":"Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis","volume":"131","author":"Axelsson","year":"2022","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/dta.2330","article-title":"Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high performance liquid chromatography\u2013tandem mass spectrometry","volume":"10","author":"Rocchi","year":"2018","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461615","article-title":"Sample preparation strategies for the determination of psychoactive substances in biological fluids","volume":"1633","author":"Esteve-Turrillas","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2026.113102_bib7","unstructured":"European Union Drugs Agency (EUDA). New psychoactive substances \u2013 the current situation in Europe [Internet]. EUDA: Luxembourg; Jun 5, 2025; accessed Jan 7, 2025."},{"key":"10.1016\/j.forsciint.2026.113102_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chroma.2014.11.024","article-title":"Liquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid: Cross reactivity study with an on-site immunoassay device","volume":"1374","author":"de Castro","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2026.113102_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.talanta.2017.06.022","article-title":"A fast bioanalytical method based on microextraction by packed sorbent and UPLC\u2013MS\/MS for determining new psychoactive substances in oral fluid","volume":"174","author":"Ares","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.forsciint.2026.113102_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jat\/bkx055","article-title":"A validated method for the detection of 32 bath salts in oral fluid","volume":"41","author":"Williams","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fphar.2018.00206","article-title":"Acute pharmacological effects of 2C-B in humans: An observational study","volume":"9","author":"Papaseit","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.forsciint.2026.113102_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00216-018-1428-5","article-title":"Simultaneous determination of 20 drugs of abuse in oral fluid using ultrasound-assisted dispersive liquid\u2013liquid microextraction","volume":"411","author":"Fern\u00e1ndez","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2026.113102_bib13","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1080\/10826084.2019.1646285","article-title":"Drug use by music festival attendees: A novel triangulation approach using self-reported data and test results of oral fluid and pooled urine samples","volume":"54","author":"Gjerde","year":"2019","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.forsciint.2026.113102_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpba.2019.02.039","article-title":"Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC\u2013MS\/MS) analysis of psychoactive drugs in oral fluid","volume":"170","author":"Malaca","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/dta.2595","article-title":"Pharmacokinetic properties of 4-fluoroamphetamine in serum and oral fluid after oral ingestion","volume":"11","author":"Toennes","year":"2019","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120158","article-title":"Development of pipette tip-based poly(methacrylic acid-co-ethylene glycol dimethacrylate) monolith for the extraction of drugs of abuse from oral fluid samples","volume":"205","author":"Sorribes-Soriano","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.forsciint.2026.113102_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fchem.2020.00439","article-title":"Validation of a bioanalytical method for the determination of synthetic and natural cannabinoids (new psychoactive substances) in oral fluid samples by means of HPLC-MS\/MS","volume":"8","author":"Cal\u00f2","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.forsciint.2026.113102_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jat\/bkaa089","article-title":"Screening of 104 new psychoactive substances (NPS) and other drugs of abuse in oral fluid by LC\u2013MS\/MS","volume":"44","author":"da Cunha","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jat\/bkaa103","article-title":"A comprehensive HPLC\u2013MS\/MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid","volume":"44","author":"Di Trana","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jat\/bkz114","article-title":"Stability and degradation pathways of different psychoactive drugs in neat and in buffered oral fluid","volume":"44","author":"Marchei","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108962","article-title":"Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties","volume":"227","author":"da Cunha","year":"2021","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.forsciint.2026.113102_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.705643","article-title":"Acute pharmacological effects and oral fluid concentrations of the synthetic cannabinoids JWH-122 and JWH-210 in humans after self-administration: An observational study","volume":"12","author":"Mart\u00ednez","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.forsciint.2026.113102_bib23","first-page":"788","article-title":"A comparison of acute pharmacological effects of methylone and MDMA administration in humans and oral fluid concentrations as biomarkers of exposure","volume":"10","author":"Poyatos","year":"2021","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.forsciint.2026.113102_bib24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/1556-4029.15067","article-title":"Oral fluid analysis to monitor recent exposure to synthetic cannabinoids in a high-risk subpopulation","volume":"67","author":"Pascali","year":"2022","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2026.113102_bib25","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00216-023-04751-2","article-title":"Determination of synthetic hallucinogens in oral fluids by microextraction by packed sorbent and liquid chromatography\u2013tandem mass spectrometry","volume":"415","author":"Lesne","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2026.113102_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342529","article-title":"Target and suspect screening of psychoactive substances in seizures and oral fluid exploiting retention time prediction and LC-MS\/MS analysis","volume":"1303","author":"Di Francesco","year":"2024","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.forsciint.2026.113102_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116139","article-title":"Target analysis of psychoactive drugs in oral fluid by QuEChERS extraction and LC-MS\/MS","volume":"244","author":"J\u00fanior","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jat\/bkae018","article-title":"Green analytical toxicology procedure for determination of ketamine, its metabolites and analogues in oral fluid samples using dispersive liquid\u2013liquid microextraction (DLLME)","volume":"48","author":"Oliveira","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mas.21715","article-title":"Eight key rules for successful data-dependent acquisition in mass spectrometry-based metabolomics","volume":"42","author":"Defossez","year":"2023","journal-title":"Mass. Spectrom. Rev."},{"key":"10.1016\/j.forsciint.2026.113102_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2017.10.043","article-title":"Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry-based metabolomics: Where do we stand?","volume":"1526","author":"Fenaille","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2026.113102_bib31","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1021\/jasms.1c00124","article-title":"Variable data independent acquisition and data mining exploring feature-based molecular networking analysis for untargeted screening of synthetic cannabinoids in oral fluid","volume":"32","author":"Cavalcanti","year":"2021","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"10.1016\/j.forsciint.2026.113102_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jat\/bkw118","article-title":"Simultaneous screening and quantification of basic, neutral and acidic drugs in blood using UPLC-QTOF-MS","volume":"41","author":"Bidny","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib33","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/dta.2120","article-title":"Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition","volume":"9","author":"Mollerup","year":"2017","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.forsciint.2018.03.039","article-title":"Systematic forensic toxicological analysis by liquid chromatography\u2013quadrupole\u2013time-of-flight mass spectrometry in serum and comparison to gas chromatography\u2013mass spectrometry","volume":"287","author":"Grapp","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2026.113102_bib35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/jat\/bkad069","article-title":"Comprehensive toxicological screening of common drugs of abuse, new psychoactive substances and cannabinoids in blood using supported liquid extraction and liquid chromatography\u2013quadrupole time-of-flight mass spectrometry","volume":"47","author":"Ayala","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/FTD.0000000000001163","article-title":"Comprehensive monitoring of psychoactive substances in psychiatric patients using liquid chromatography-high-resolution mass spectrometry","volume":"46","author":"La Maida","year":"2024","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.forsciint.2026.113102_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jat\/bkw043","article-title":"Broad screening and identification of novel psychoactive substances in plasma by high-performance liquid chromatography\u2013high-resolution mass spectrometry and post-run library matching","volume":"40","author":"Montesano","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/dta.1683","article-title":"Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry in post-mortem urine","volume":"7","author":"Sundstr\u00f6m","year":"2015","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hup.2512","article-title":"New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening","volume":"31","author":"Heikman","year":"2016","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.forsciint.2026.113102_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/15563650.2017.1360496","article-title":"Recreational drug use at a major music festival: Trend analysis of anonymised pooled urine","volume":"56","author":"Hoegberg","year":"2018","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bcp.14239","article-title":"Evaluation of long-term detection trends of new psychoactive substances in pooled urine from city street portable urinals (London, UK)","volume":"86","author":"Archer","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2026.113102_bib42","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.3390\/ijms22084000","article-title":"Ultra-high performance liquid chromatography\u2013high resolution mass spectrometry and high-sensitivity gas chromatography\u2013mass spectrometry screening of classic drugs and new psychoactive substances and metabolites in urine of consumers","volume":"22","author":"Marchei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.forsciint.2026.113102_bib43","first-page":"645","article-title":"New psychoactive substances consumption in opioid-use disorder patients","volume":"11","author":"Al\u00edas-Ferri","year":"2022","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.forsciint.2026.113102_bib44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1017\/S1049023X22001285","article-title":"Pooled urine analysis at a Belgian music festival: Trends in alcohol consumption and recreational drug use","volume":"37","author":"Geuens","year":"2022","journal-title":"Prehosp. Disaster Med."},{"key":"10.1016\/j.forsciint.2026.113102_bib45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/dta.2232","article-title":"Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs population","volume":"10","author":"Wille","year":"2018","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jat\/bkab114","article-title":"Rethinking drug analysis in health care: High-throughput analysis of 71 drugs of abuse in oral fluid using ion mobility\u2013high-resolution mass spectrometry","volume":"46","author":"Bergstr\u00f6m","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2026.113107","article-title":"Evaluating the trends and impact of COVID-19 on illicit drug and benzodiazepine use in drivers: A retrospective large-scale study based on oral fluid testing","volume":"282","author":"Blanco-Ces","year":"2026","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.forsciint.2026.113102_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/jat\/bkz030","article-title":"HighResNPS.com: An online crowd-sourced HR-MS database for suspect and non-targeted screening of new psychoactive substances","volume":"43","author":"Mardal","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib49","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: Communicating confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.forsciint.2026.113102_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-anchem-091222-112115","article-title":"Efficient validation strategies in environmental analytical chemistry: A focus on organic micropollutants in water samples","volume":"16","author":"Hern\u00e1ndez","year":"2023","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.forsciint.2026.113102_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116335","article-title":"vitro biotransformation of 3-methylmethcathinone (3-MMC) through incubation with human liver microsomes and cytosol and application to in vivo samples","volume":"248","author":"Van Wichelen","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2026.113102_bib52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1208\/s12248-024-00940-8","article-title":"3-CMC, 4-CMC, and 4-BMC human metabolic profiling: New major pathways to document consumption of methcathinone analogues?","volume":"26","author":"Berardinelli","year":"2024","journal-title":"AAPS J."},{"key":"10.1016\/j.forsciint.2026.113102_bib53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.talanta.2019.04.057","article-title":"Novel sample-substrates for the determination of new psychoactive substances in oral fluid by desorption electrospray ionization-high resolution mass spectrometry","volume":"202","author":"Bianchi","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.forsciint.2026.113102_bib54","unstructured":"Federal Register. Mandatory guidelines for federal workplace drug testing programs\u2014authorized testing panels. 2025."},{"key":"10.1016\/j.forsciint.2026.113102_bib55","unstructured":"European Workplace Drug Testing Society. European guidelines for workplace drug testing in oral fluid. 2022."},{"key":"10.1016\/j.forsciint.2026.113102_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.14117","article-title":"Epidemiology of new psychoactive substances in relation to traditional drugs of abuse in clinical oral fluid samples","volume":"136","author":"Axelsson","year":"2025","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113102_bib57","first-page":"331","article-title":"Identification of di(beta-phenylisopropyl)amine as the main ingredient in illicit amphetamine tablets","volume":"38","author":"Ottaviano","year":"2002","journal-title":"Ann. Ist. Super. Sanita"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073826002902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073826002902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:27:11Z","timestamp":1793622431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073826002902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"alternative-id":["S0379073826002902"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2026.113102","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC-HRMS suspect screening for expanded detection of (new) psychoactive substances in oral fluid: a practical approach for forensic casework","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2026.113102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113102"}}